Breaking News

Idifarma Makes Serialization Investment

Equipment to be operational six months ahead of the EU FMD deadline

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Spanish contract development and manufacturing organization (CDMO) Idifarma said it will meet upcoming EU serialization regulations with a €200,000 investment. The investment will include the installation of the Antares Vision Print&Check EVO-TE carton serialization station at its EU-GMP approved plant in Pamplona, Spain and comes ahead of the EU Falsified Medicines Directive’s (EU FMD) February 2019 deadline for the serialization of licensed drug products. The industry-wide EU F...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters